MONTANOVA CAPITAL, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001569064

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2024 · 98 positions · Total reported value $2.72B · Top-10 concentration 47.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.3% · 21 new · 17 cut · 14 exited

Active Share (vs S&P 500): 88.7% · vs QQQ: 90.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +26.5% · vs SPY +11.7% · Prev Value $3.92B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2024 13F filing, MONTANOVA CAPITAL, LLC disclosed 98 equity positions with a combined reported value of $2.72B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 47.8% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were SPY ($272.11M), BHVN ($180.46M), INSM ($168.96M). By sector, the heaviest allocations are Health Care 45.2%, Technology 15.0%. Versus the prior quarter, allocation shifted toward Health Care (+2.8pp), Technology (+2.2pp) and away from Communication Services (-0.9pp), Miscellaneous (-1.4pp).

Versus the prior quarter, MONTANOVA CAPITAL, LLC opened 21 new positions, trimmed 17 and fully exited 14, a turnover rate of 47.3% of positions. The portfolio's overlap with the prior quarter was 81% of names.

The largest new positions opened in Q2 2024 were SYY ($37.19M), CTNM ($36.16M), ERAS ($32.49M).

Of the 14 positions fully exited versus the prior quarter, the largest were QQQ ($86.58M), ARGX ($47.99M), BCYC ($22.77M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • SYY SYSCO CORP · $37.19M
  • CTNM CONTINEUM THERAPEUTICS INC CL A · $36.16M
  • ERAS ERASCA INC · $32.49M
  • MCD MCDONALDS CORP · $28.14M
  • TSLA TESLA INC · $26.70M
  • ABEO ABEONA THERAPEUTICS INC · $15.63M
  • GLUE MONTE ROSA THERAPEUTICS INC · $9.94M
  • EXAS EXACT SCIENCES CORP · $3.98M

Fully Exited (vs previous quarter)

  • QQQ INVESCO QQQ TR · prev qtr: $86.58M
  • ARGX ARGENX SE · prev qtr: $47.99M
  • BCYC BICYCLE THERAPEUTICS PLC · prev qtr: $22.77M
  • FATE Fate Therapeutics Inc · prev qtr: $18.81M
  • HLT HILTON WORLDWIDE HLDGS INC · prev qtr: $16.75M
  • CRM SALESFORCE INC · prev qtr: $16.58M
  • SBUX STARBUCKS CORP · prev qtr: $15.81M
  • GPN GLOBAL PMTS INC · prev qtr: $14.18M

Insider Transactions (Form 4)

Latest MONTANOVA CAPITAL, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-20 Opt exercise Veradermics, Inc 151,000 — SEC filing
2026-08-20 Opt exercise Veradermics, Inc 149,000 — SEC filing
2026-08-19 Sell Veradermics, Inc 59,399 $107.25 SEC filing
2026-08-19 Sell Veradermics, Inc 690,601 $107.25 SEC filing

All insider transactions →

Fund Profile

Montanova Capital, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 96 positions worth $5.47B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-79962 (status: Approved), registered 2014-06-26
  • Regulatory AUM (Form ADV): $7.87B as of 2026-07-01
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds
  • Website: montanova.com

Portfolio Structure

  • 96 positions · $5.47B reported value (Q2 2026)
  • Top 10 holdings = 49.1% of reported value
  • Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 13.0%
  • Average position size: $56.96M

Sector Tilt

  • Health Care 50.9%
  • Information Technology 14.5%
  • Consumer Discretionary 8.3%
  • (classified holdings cover 83% of value)

Quarterly Activity

  • Q2 2026: 21 new, 26 added, 17 reduced, 14 exited
  • 32 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 500.00K $272.11M 10.00%
10.00%
Add
2 5.20M $180.46M 6.63%
6.63%
Add
3 2.52M $168.96M 6.21%
6.21%
Add
4 7.07M $145.56M 5.35%
5.35%
Hold
5 1.57M $107.26M 3.94%
3.94%
Add
6 10.00M $93.04M 3.42%
3.42%
Add
7 2.06M $84.72M 3.11%
3.11%
Add
8 167.17K $84.29M 3.10%
3.10%
Reduce
9 1.52M $83.68M 3.07%
3.07%
Reduce
10 161.47K $82.23M 3.02%
3.02%
Add
11 363.36K $76.53M 2.81%
2.81%
Add
12 356.27K $68.85M 2.53%
2.53%
Hold
13 8.03M $64.34M 2.36%
2.36%
Add
14 350.75K $60.96M 2.24%
2.24%
Add
15 346.00K $56.12M 2.06%
2.06%
Add
16 91.44K $49.55M 1.82%
1.82%
Add
17 4.19M $49.38M 1.81%
1.81%
Hold
18 1.87M $49.22M 1.81%
1.81%
Reduce
19 104.03K $46.50M 1.71%
1.71%
Add
20 5.18M $45.03M 1.65%
1.65%
Add
21 354.49K $41.85M 1.54%
1.54%
Reduce
22 2.19M $41.79M 1.53%
1.53%
Reduce
23 520.90K $37.19M 1.37%
1.37%
New
24 2.05M $36.16M 1.33%
1.33%
New
25 560.61K $35.68M 1.31%
1.31%
Add
26 77.95K $35.26M 1.29%
1.29%
Reduce
27 245.11K $34.61M 1.27%
1.27%
Add
28 204.96K $32.58M 1.20%
1.20%
Reduce
29 13.77M $32.49M 1.19%
1.19%
New
30 431.98K $32.39M 1.19%
1.19%
Add
31 1.71M $31.77M 1.17%
1.17%
Add
32 110.43K $28.14M 1.03%
1.03%
New
33 145.04K $28.09M 1.03%
1.03%
Reduce
34 134.91K $26.70M 0.98%
0.98%
New
35 609.90K $25.15M 0.92%
0.92%
Reduce
36 398.50K $24.97M 0.92%
0.92%
Add
37 1.52M $24.27M 0.89%
0.89%
Hold
38 9.34M $22.98M 0.84%
0.84%
Add
39 7.71M $22.59M 0.83%
0.83%
Add
40 251.69K $19.38M 0.71%
0.71%
Reduce
41 409.95K $18.07M 0.66%
0.66%
Add
42 4.86M $17.01M 0.62%
0.62%
Add
43 2.54M $15.75M 0.58%
0.58%
Reduce
44 3.69M $15.63M 0.57%
0.57%
New
45 957.30K $14.58M 0.54%
0.54%
Hold
46 90.10K $13.17M 0.48%
0.48%
Hold
47 1.69M $11.82M 0.43%
0.43%
Add
48 946.56K $11.00M 0.40%
0.40%
Hold
49 210.70K $10.22M 0.38%
0.38%
Hold
50 5.73M $9.98M 0.37%
0.37%
Hold

FAQ

What did MONTANOVA CAPITAL, LLC buy in 2024-Q2?

In its 2024-Q2 13F filing, MONTANOVA CAPITAL, LLC reported 98 equity positions worth $2.72B in aggregate; its largest disclosed positions were SPY ($272.11M), BHVN ($180.46M), INSM ($168.96M).

How large is MONTANOVA CAPITAL, LLC's portfolio?

MONTANOVA CAPITAL, LLC reported $2.72B of long equity holdings across 98 positions as of 2024-Q2. Top-10 holdings account for 47.8% of reported value.

What is MONTANOVA CAPITAL, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/montanova-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →